How Much Did Kapiva Raise? Funding & Key Investors

Date
March 31, 2025
Kapiva

Total amount raised

$53.5 Million

Latest funding date

9/1/2024

Kapiva

Location

Title

LINKEDIN

https://www.crunchbase.com/organization/kapiva-ayurveda/financial_details
Use Clay to find other emails
Status
Verified
Use Clay's email finder to get anyone's work email in seconds.

Kapiva has successfully raised funding through 9 rounds, with the most recent being a Series D round led by 360 ONE Asset and Vertex Growth Fund. The company is backed by 11 investors, including Vertex Ventures Southeast Asia & India and Vertex Growth Fund.

Kapiva specializes in modern Ayurvedic products aimed at providing complete nutrition, offering a variety of solutions for health concerns such as gym foods, heart care, and weight management. Keep reading to explore the intricacies of Kapiva's fundraising journey and the investors backing this innovative platform.

What Is Kapiva?

Kapiva is a healthcare and wellness company that merges traditional Ayurveda with modern science to deliver natural health solutions. Based in Bengaluru, Karnataka, India, the company operates in multiple industries including E-Commerce, Health Care, Retail, and Wellness.

Founded by Adret Retail Private Limited, Kapiva has a workforce of 501-1000 employees. The company offers a wide range of Ayurvedic products aimed at providing complete nutrition and wellness solutions, available through its e-commerce platform.

How Much Funding Has Kapiva Raised?

  1. Funding Round: Seed
    • Amount Raised: Not publicly disclosed
    • Date: November 2017
    • Lead Investors: Not publicly disclosed
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: Initial capital to launch and develop the product line.
  2. Funding Round: Series A
    • Amount Raised: USD 2,500,000
    • Date: January 2019
    • Lead Investors: Fireside Ventures
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To scale operations and expand product offerings.
  3. Funding Round: Series A
    • Amount Raised: USD 2,000,000
    • Date: April 2020
    • Lead Investors: Not publicly disclosed
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To enhance marketing efforts and increase market penetration.
  4. Funding Round: Series B
    • Amount Raised: USD 11,000,000
    • Date: January 2021
    • Lead Investors: Not publicly disclosed
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To support product development and geographical expansion.
  5. Funding Round: Series Unknown
    • Amount Raised: Not publicly disclosed
    • Date: October 2021
    • Lead Investors: Malaika Arora
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To leverage celebrity endorsement for brand visibility.
  6. Funding Round: Series C
    • Amount Raised: USD 28,000,000
    • Date: September 2022
    • Lead Investors: 3one4 Capital, OrbiMed, Vertex Ventures
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To expand product lines and enhance distribution channels.
  7. Funding Round: Series C
    • Amount Raised: INR 835,000,000 (approximately USD 10,000,000)
    • Date: September 2024
    • Lead Investors: OrbiMed
    • Valuation at Round: USD 80,000,000
    • Motivation Behind the Round: To support company growth and market expansion.
  8. Funding Round: Series D
    • Amount Raised: USD 28,000,000
    • Date: September 2025
    • Lead Investors: 360 ONE Asset, Vertex Growth Fund
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To further scale operations and enter new markets.
  9. Funding Round: Secondary Market
    • Amount Raised: USD 32,000,000
    • Date: September 2025
    • Lead Investors: 360 ONE Asset, Vertex Growth Fund
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To provide liquidity to early investors and employees.

Total Amount Raised: USD 143,500,000. Current Valuation: Not publicly disclosed.

Key Investors

  • Vertex Ventures Southeast Asia & India
    • Details: Vertex Ventures Southeast Asia & India is a venture capital firm focusing on investments in Southeast Asia and India. They are known for supporting early-stage companies with high growth potential.
    • Investment Focus Areas: Technology, healthcare, consumer sectors
    • Notable Investments: Not publicly disclosed
  • 360 ONE Asset
    • Details: 360 ONE Asset is an asset management firm that provides a range of investment solutions. They focus on delivering consistent returns through diversified investment strategies.
    • Investment Focus Areas: General asset management across various sectors
    • Notable Investments: Not publicly disclosed
  • Vertex Growth Fund
    • Details: Vertex Growth Fund is a growth-stage venture capital fund. They specialize in supporting companies that have demonstrated significant growth and are looking to scale further.
    • Investment Focus Areas: Growth-stage companies across various sectors
    • Notable Investments: Not publicly disclosed
  • OrbiMed Asia
    • Details: OrbiMed Asia is a leading investment firm focused on the healthcare and life sciences sectors. They have a strong presence in Asia and invest in companies at various stages of development.
    • Investment Focus Areas: Healthcare, life sciences
    • Notable Investments: Not publicly disclosed
  • 3One4 Capital
    • Details: 3One4 Capital is an early-stage venture capital firm. They focus on investing in technology, consumer, and healthcare sectors, supporting startups with innovative solutions.
    • Investment Focus Areas: Technology, consumer, healthcare
    • Notable Investments: Licious, Darwinbox, Open

What's Next for Kapiva?

Kapiva stands at the cusp of significant growth opportunities, driven by the rising consumer interest in natural and organic health products. With the recent funding, the company aims to expand its product lines and enhance market reach, positioning itself to capture a larger share of the D2C ayurvedic nutrition market.

Future fundraising efforts are likely as Kapiva continues its Series C round, targeting a total of Rs 250 crore. This capital will be crucial for scaling operations and entering new markets, ensuring sustained growth and market presence.

However, challenges such as high competition and managing operational losses could pose hurdles. Navigating these obstacles while maintaining profitability will be key to Kapiva's long-term success.

Use Clay to Get Funding Data

Sales professionals, take your strategy to the next level by leveraging Clay’s platform to access comprehensive fundraising data on companies like Kapiva and gather other critical business insights. Sign up for free and unlock the potential of data-driven decision-making today.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles